Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Courter

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Clinical Engineering|September 8, 1980
The professional development degree for biomedical engineersS S Courter
Journal - California Dental Association|January 1, 1970
Changing attitudes of dentistry in relation to community healthS Courter, K Friedrich, B Lake
Journal of Clinical Immunology|July 1, 1993
Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodiesC Cunningham-Rundles, Z Zhou, S Mankarious, et al.
Thrombosis and Haemostasis|April 1, 1997
A multicenter study of recombinant factor VIII (Recombinate) in previously treated patients with hemophilia A. The Recombinate Previously Treated Patient Study GroupG C White, S Courter, G L Bray, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
A multicenter study of recombinant factor VIII (Recombinate(TM) ) in previously treated patients with hemophilia AG C White, S Courter, G L Bray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Hepatic artery ligation and portal vein infusion for liver metastases from colon cancerL R Laufman, T A Nims, J T Guy, et al.
Seminars in Hematology|June 13, 1998
Clinical evaluation of recombinant factor IXG White, A Shapiro, M Ragni, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Epitope specificity and functional characterization of factor VIII inhibitorsD Scandella, C Kessler, P Esmon, et al.
Transactions of the American Clinical and Climatological Association|March 17, 2011
Bed Pan DeathsJ McGuire, R S Green, S Courter, et al.
Blood|May 1, 1994
A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study GroupG L Bray, E D Gomperts, S Courter, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Engineering|September 8, 1980
The professional development degree for biomedical engineersS S Courter
Journal - California Dental Association|January 1, 1970
Changing attitudes of dentistry in relation to community healthS Courter, K Friedrich, B Lake
Journal of Clinical Immunology|July 1, 1993
Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodiesC Cunningham-Rundles, Z Zhou, S Mankarious, et al.
Thrombosis and Haemostasis|April 1, 1997
A multicenter study of recombinant factor VIII (Recombinate) in previously treated patients with hemophilia A. The Recombinate Previously Treated Patient Study GroupG C White, S Courter, G L Bray, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
A multicenter study of recombinant factor VIII (Recombinate(TM) ) in previously treated patients with hemophilia AG C White, S Courter, G L Bray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Hepatic artery ligation and portal vein infusion for liver metastases from colon cancerL R Laufman, T A Nims, J T Guy, et al.
Seminars in Hematology|June 13, 1998
Clinical evaluation of recombinant factor IXG White, A Shapiro, M Ragni, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Epitope specificity and functional characterization of factor VIII inhibitorsD Scandella, C Kessler, P Esmon, et al.
Transactions of the American Clinical and Climatological Association|March 17, 2011
Bed Pan DeathsJ McGuire, R S Green, S Courter, et al.
Blood|May 1, 1994
A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study GroupG L Bray, E D Gomperts, S Courter, et al.
Pageof 1